JP4654038B2 - キメラアルファｑ−ガストデューシンｇタンパク質 - Google Patents

Info

Publication number

JP4654038B2

JP4654038B2 JP2004559553A JP2004559553A JP4654038B2 JP 4654038 B2 JP4654038 B2 JP 4654038B2 JP 2004559553 A JP2004559553 A JP 2004559553A JP 2004559553 A JP2004559553 A JP 2004559553A JP 4654038 B2 JP4654038 B2 JP 4654038B2

Authority

JP

Japan

Prior art keywords

protein

chimeric

receptor

cells

taste

Prior art date

2002-12-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Lifetime

Links

• Espacenet
• Global Dossier
• Discuss

• 108091006027 G proteins Proteins 0.000 title claims abstract description 76
• 102000030782 GTP binding Human genes 0.000 title claims abstract description 76
• 108091000058 GTP-Binding Proteins 0.000 title claims abstract description 76
• 235000019658 bitter taste Nutrition 0.000 claims abstract description 25
• 235000019583 umami taste Nutrition 0.000 claims abstract description 18
• 235000019605 sweet taste sensations Nutrition 0.000 claims abstract description 9
• 235000019607 umami taste sensations Nutrition 0.000 claims abstract description 9
• 210000004027 cell Anatomy 0.000 claims description 92
• 108020003175 receptors Proteins 0.000 claims description 57
• 108091005708 gustatory receptors Proteins 0.000 claims description 49
• 150000001875 compounds Chemical class 0.000 claims description 41
• 230000014509 gene expression Effects 0.000 claims description 30
• 108090000623 proteins and genes Proteins 0.000 claims description 26
• 238000000034 method Methods 0.000 claims description 24
• 230000000694 effects Effects 0.000 claims description 22
• 102100039215 Guanine nucleotide-binding protein G(t) subunit alpha-3 Human genes 0.000 claims description 20
• 108010005995 gustducin Proteins 0.000 claims description 20
• 239000011575 calcium Substances 0.000 claims description 19
• 239000013604 expression vector Substances 0.000 claims description 14
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 13
• 229910052791 calcium Inorganic materials 0.000 claims description 13
• 102000004169 proteins and genes Human genes 0.000 claims description 13
• 150000001413 amino acids Chemical class 0.000 claims description 11
• 230000003834 intracellular effect Effects 0.000 claims description 11
• 239000002299 complementary DNA Substances 0.000 claims description 10
• 150000007523 nucleic acids Chemical class 0.000 claims description 10
• 210000004962 mammalian cell Anatomy 0.000 claims description 9
• 108020004707 nucleic acids Proteins 0.000 claims description 8
• 102000039446 nucleic acids Human genes 0.000 claims description 8
• 230000001939 inductive effect Effects 0.000 claims description 5
• 238000000423 cell based assay Methods 0.000 claims description 4
• 239000002773 nucleotide Substances 0.000 claims description 4
• 125000003729 nucleotide group Chemical group 0.000 claims description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 101000887490 Homo sapiens Guanine nucleotide-binding protein G(z) subunit alpha Proteins 0.000 claims description 3
• 102000052301 human GNAZ Human genes 0.000 claims description 3
• 230000008569 process Effects 0.000 claims description 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 2
• 238000012258 culturing Methods 0.000 claims 1
• 230000014616 translation Effects 0.000 claims 1
• 238000003556 assay Methods 0.000 abstract description 35
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract description 19
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract description 19
• 230000036327 taste response Effects 0.000 abstract description 7
• 102000005962 receptors Human genes 0.000 description 56
• 239000003446 ligand Substances 0.000 description 34
• -1 benzyl beta-D-galactoside Chemical compound 0.000 description 31
• HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 15
• 235000019640 taste Nutrition 0.000 description 15
• 239000013598 vector Substances 0.000 description 15
• 239000000126 substance Substances 0.000 description 14
• 230000004913 activation Effects 0.000 description 13
• 239000001963 growth medium Substances 0.000 description 11
• 235000018102 proteins Nutrition 0.000 description 11
• 235000009508 confectionery Nutrition 0.000 description 10
• 229960003136 leucine Drugs 0.000 description 10
• 239000012981 Hank's balanced salt solution Substances 0.000 description 8
• 239000004098 Tetracycline Substances 0.000 description 8
• 229940024606 amino acid Drugs 0.000 description 8
• 235000001014 amino acid Nutrition 0.000 description 8
• 230000005540 biological transmission Effects 0.000 description 8
• 108020001507 fusion proteins Proteins 0.000 description 8
• 102000037865 fusion proteins Human genes 0.000 description 8
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
• 229960002180 tetracycline Drugs 0.000 description 8
• 229930101283 tetracycline Natural products 0.000 description 8
• 235000019364 tetracycline Nutrition 0.000 description 8
• 150000003522 tetracyclines Chemical class 0.000 description 8
• NEZJDVYDSZTRFS-RMPHRYRLSA-N Phenyl beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-RMPHRYRLSA-N 0.000 description 7
• YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 6
• 239000012634 fragment Substances 0.000 description 6
• 229960005190 phenylalanine Drugs 0.000 description 6
• 230000019491 signal transduction Effects 0.000 description 6
• 238000001890 transfection Methods 0.000 description 6
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 5
• OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 5
• FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 229910001424 calcium ion Inorganic materials 0.000 description 5
• 235000013305 food Nutrition 0.000 description 5
• 230000005714 functional activity Effects 0.000 description 5
• 108090000765 processed proteins & peptides Proteins 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 238000003146 transient transfection Methods 0.000 description 5
• 229960004295 valine Drugs 0.000 description 5
• 239000011534 wash buffer Substances 0.000 description 5
• GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 4
• WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 4
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
• YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 4
• 108010011485 Aspartame Proteins 0.000 description 4
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
• 108020004414 DNA Proteins 0.000 description 4
• 241000208251 Gymnema Species 0.000 description 4
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
• 101000892439 Homo sapiens Taste receptor type 2 member 10 Proteins 0.000 description 4
• 101000787850 Homo sapiens Taste receptor type 2 member 38 Proteins 0.000 description 4
• 239000004395 L-leucine Substances 0.000 description 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
• QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 4
• REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
• 229960003767 alanine Drugs 0.000 description 4
• BBFQZRXNYIEMAW-UHFFFAOYSA-N aristolochic acid I Chemical compound C1=C([N+]([O-])=O)C2=C(C(O)=O)C=C3OCOC3=C2C2=C1C(OC)=CC=C2 BBFQZRXNYIEMAW-UHFFFAOYSA-N 0.000 description 4
• 239000000605 aspartame Substances 0.000 description 4
• 235000010357 aspartame Nutrition 0.000 description 4
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
• 229960003438 aspartame Drugs 0.000 description 4
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
• 229940098773 bovine serum albumin Drugs 0.000 description 4
• 239000001110 calcium chloride Substances 0.000 description 4
• 229910001628 calcium chloride Inorganic materials 0.000 description 4
• 230000008878 coupling Effects 0.000 description 4
• 238000010168 coupling process Methods 0.000 description 4
• 238000005859 coupling reaction Methods 0.000 description 4
• 235000015872 dietary supplement Nutrition 0.000 description 4
• 150000002500 ions Chemical class 0.000 description 4
• 229960000310 isoleucine Drugs 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 239000013612 plasmid Substances 0.000 description 4
• DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 108010063331 type 2 taste receptors Proteins 0.000 description 4
• 239000004474 valine Substances 0.000 description 4
• KLBQQJXKVACGIQ-UHFFFAOYSA-N Abrusoside E Natural products C1C=C(C)C(=O)OC1C(C)C(C1(CCC23C4)C)CCC1(C)C2CCC(C1(C)C(O)=O)C34CCC1OC1OC(CO)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O KLBQQJXKVACGIQ-UHFFFAOYSA-N 0.000 description 3
• WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 3
• 206010059866 Drug resistance Diseases 0.000 description 3
• 241000588724 Escherichia coli Species 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 239000012097 Lipofectamine 2000 Substances 0.000 description 3
• 108091028043 Nucleic acid sequence Proteins 0.000 description 3
• NEZJDVYDSZTRFS-UHFFFAOYSA-N O-phenyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1 NEZJDVYDSZTRFS-UHFFFAOYSA-N 0.000 description 3
• KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 3
• 239000004376 Sucralose Substances 0.000 description 3
• 102100025867 Taste receptor type 2 member 38 Human genes 0.000 description 3
• 102000014384 Type C Phospholipases Human genes 0.000 description 3
• 108010079194 Type C Phospholipases Proteins 0.000 description 3
• 239000000619 acesulfame-K Substances 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 229940088710 antibiotic agent Drugs 0.000 description 3
• 229960005261 aspartic acid Drugs 0.000 description 3
• 230000001580 bacterial effect Effects 0.000 description 3
• 235000013361 beverage Nutrition 0.000 description 3
• ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
• PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 3
• QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 3
• 210000003527 eukaryotic cell Anatomy 0.000 description 3
• LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 3
• LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
• MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
• 150000002611 lead compounds Chemical class 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 3
• 229920001184 polypeptide Polymers 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 229960002662 propylthiouracil Drugs 0.000 description 3
• NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• 235000019408 sucralose Nutrition 0.000 description 3
• BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
• 108010065275 type 1 taste receptors Proteins 0.000 description 3
• 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 2
• QATISCJMIITVAB-UHFFFAOYSA-N 2-[[17-[5-[4,5-dihydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydro Chemical compound C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O QATISCJMIITVAB-UHFFFAOYSA-N 0.000 description 2
• XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
• NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 2
• RETHOWGCGNZYSL-UHFFFAOYSA-N 6-[(11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl)oxy]-5-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid Chemical compound CC1(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C(O)=O)CC5C4=CC(=O)C3C2(C)CCC1OC1OC(C(O)=O)C(O)C(O)C1OC1OCC(O)(CO)C1O RETHOWGCGNZYSL-UHFFFAOYSA-N 0.000 description 2
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
• PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
• DRSIUFQRQCNVHS-UHFFFAOYSA-N Carnosifloside II Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(=O)CC2(C)C1C(C)CCC=C(C)COC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O DRSIUFQRQCNVHS-UHFFFAOYSA-N 0.000 description 2
• UHWXBWBOPABGIG-UHFFFAOYSA-N Carnosifloside III Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(=O)CC2(C)C1C(C)CCC=C(C)COC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O UHWXBWBOPABGIG-UHFFFAOYSA-N 0.000 description 2
• WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 2
• 230000004544 DNA amplification Effects 0.000 description 2
• 238000001712 DNA sequencing Methods 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• HDVAWXXJVMJBAR-UHFFFAOYSA-N Epilupinine Natural products C1CCCC2C(CO)CCCN21 HDVAWXXJVMJBAR-UHFFFAOYSA-N 0.000 description 2
• YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
• 239000001329 FEMA 3811 Substances 0.000 description 2
• 239000001776 FEMA 4720 Substances 0.000 description 2
• AWVSBBCABYAQJD-UHFFFAOYSA-N Gaudichaudioside F Natural products CC(=C/CO)CCC1=C(CC(OC2OCC(O)C(O)C2O)C3C(C)(CO)CCCC13C)C=CC(=O)C AWVSBBCABYAQJD-UHFFFAOYSA-N 0.000 description 2
• KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 2
• GLLUYNRFPAMGQR-UHFFFAOYSA-N Glycyphyllin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-UHFFFAOYSA-N 0.000 description 2
• YGMIBVIKXJJQQJ-MSOSQAFRSA-N Grosshemin Chemical compound O[C@H]1CC(=C)[C@@H]2CC(=O)[C@@H](C)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 YGMIBVIKXJJQQJ-MSOSQAFRSA-N 0.000 description 2
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 2
• OHGFKHHCPIGSKE-UHFFFAOYSA-N Periandrin V Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(C=O)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OCC(O)C(O)C1O OHGFKHHCPIGSKE-UHFFFAOYSA-N 0.000 description 2
• ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
• LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
• HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 2
• SABFJVXXJPRXKP-CFWZQYDDSA-N Scabraside Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1OC(C)=O)OC(=O)C=1C(=C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=CC=1)O)COC(=O)C)C(=O)C1=CC=CC=C1 SABFJVXXJPRXKP-CFWZQYDDSA-N 0.000 description 2
• OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 description 2
• UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
• 241001279009 Strychnos toxifera Species 0.000 description 2
• 102100035942 Taste receptor type 1 member 3 Human genes 0.000 description 2
• UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 108010087042 Transducin Proteins 0.000 description 2
• 102000006612 Transducin Human genes 0.000 description 2
• HDVAWXXJVMJBAR-NXEZZACHSA-N [(1s,9ar)-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-1-yl]methanol Chemical compound C1CCC[C@@H]2[C@@H](CO)CCCN21 HDVAWXXJVMJBAR-NXEZZACHSA-N 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• TYNQWWGVEGFKRU-AJDPQWBVSA-N alpha-Chaconine Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O TYNQWWGVEGFKRU-AJDPQWBVSA-N 0.000 description 2
• NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
• 239000004202 carbamide Substances 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 229960005091 chloramphenicol Drugs 0.000 description 2
• LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
• DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 2
• 229960001610 denatonium benzoate Drugs 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
• 239000003269 fluorescent indicator Substances 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 125000000457 gamma-lactone group Chemical group 0.000 description 2
• ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
• 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 description 2
• SAIULYGEZGWEDU-UHFFFAOYSA-N humulinone Chemical compound CC(C)CC(=O)C1=C(O)C(O)(C(=O)CC=C(C)C)C(O)(CC=C(C)C)C1=O SAIULYGEZGWEDU-UHFFFAOYSA-N 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
• KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• STKUCSFEBXPTAY-GSUVRYNNSA-N methyl (4s,5z,6s)-5-ethylidene-4-[2-oxo-2-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]ethyl]-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4h-pyran-3-carboxylate Chemical compound O([C@@H]\1OC=C([C@H](C/1=C/C)CC(=O)OC[C@@H]1[C@H]([C@H](O)[C@@H](O)[C@H](OCCC=2C=CC(O)=CC=2)O1)O)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O STKUCSFEBXPTAY-GSUVRYNNSA-N 0.000 description 2
• HOVAGTYPODGVJG-VEIUFWFVSA-N methyl alpha-D-mannoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-VEIUFWFVSA-N 0.000 description 2
• HOVAGTYPODGVJG-XUUWZHRGSA-N methyl beta-D-glucopyranoside Chemical compound CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-XUUWZHRGSA-N 0.000 description 2
• 239000000203 mixture Substances 0.000 description 2
• 239000003068 molecular probe Substances 0.000 description 2
• 238000002703 mutagenesis Methods 0.000 description 2
• 231100000350 mutagenesis Toxicity 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 2
• 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 2
• 235000010434 neohesperidine DC Nutrition 0.000 description 2
• 229930192588 olivieroside Natural products 0.000 description 2
• XNLFIERPGXTDDP-UHFFFAOYSA-N periandrin i Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(C=O)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O XNLFIERPGXTDDP-UHFFFAOYSA-N 0.000 description 2
• YVHGFLRTSDMQKR-UHFFFAOYSA-N periandrin iii Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(CO)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O YVHGFLRTSDMQKR-UHFFFAOYSA-N 0.000 description 2
• IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 2
• IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 2
• 235000019139 phlorizin Nutrition 0.000 description 2
• 235000005875 quercetin Nutrition 0.000 description 2
• 229960001285 quercetin Drugs 0.000 description 2
• LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
• 108091006082 receptor inhibitors Proteins 0.000 description 2
• 229940120668 salicin Drugs 0.000 description 2
• HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 2
• SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 2
• 229960001945 sparteine Drugs 0.000 description 2
• OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
• 229940013618 stevioside Drugs 0.000 description 2
• 235000019202 steviosides Nutrition 0.000 description 2
• 239000011550 stock solution Substances 0.000 description 2
• 229960005453 strychnine Drugs 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• NVLTYOJHPBMILU-UHFFFAOYSA-N taxiphyllin Natural products OC1C(O)C(O)C(CO)OC1OC(C#N)C1=CC=C(O)C=C1 NVLTYOJHPBMILU-UHFFFAOYSA-N 0.000 description 2
• 235000014620 theaflavin Nutrition 0.000 description 2
• IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 2
• 229940026509 theaflavin Drugs 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• JVYKIBAJVKEZSQ-UHFFFAOYSA-N (+)-13-hydroxylupanine Natural products C1N(C(CCC2)=O)C2C2CN3CCC(O)CC3C1C2 JVYKIBAJVKEZSQ-UHFFFAOYSA-N 0.000 description 1
• PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
• QARXXMMQVDCYGZ-YCRPNKLZSA-N (+)-cis-isohumulone Chemical compound CC(C)CC(=O)C1=C(O)[C@](O)(C(=O)CC=C(C)C)[C@@H](CC=C(C)C)C1=O QARXXMMQVDCYGZ-YCRPNKLZSA-N 0.000 description 1
• PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
• QFXOXDSHNXAFEY-UHFFFAOYSA-N (+/-)-(Z)-6-dodecen-4-olide Natural products CCCCCC=CCC1CCC(=O)O1 QFXOXDSHNXAFEY-UHFFFAOYSA-N 0.000 description 1
• WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
• PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
• LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
• RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 description 1
• SRPHMISUTWFFKJ-VOKXYEOFSA-N (23E)-2beta,16alpha,20,25- tetrahydroxy-9beta-methyl-19-nor-10alpha-lanosta-5,23-diene-3,11,22-trione Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(O)C)C=C2[C@H]1C[C@H](O)C(=O)C2(C)C SRPHMISUTWFFKJ-VOKXYEOFSA-N 0.000 description 1
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 description 1
• IXQKXEUSCPEQRD-NRNCYQGDSA-N (2S,4R,23E)-2,16beta,20-trihydroxy-9beta,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(C)OC(=O)C)C=C2[C@H]1C[C@H](O)C(=O)C2(C)C IXQKXEUSCPEQRD-NRNCYQGDSA-N 0.000 description 1
• WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 1
• GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
• XJIPREFALCDWRQ-UYQGGQRHSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-[(3r,6r)-2-hydroxy-6-[(3s,8s,9r,10r,11r,13r,14s,17r)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1h-cyclop Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJIPREFALCDWRQ-UYQGGQRHSA-N 0.000 description 1
• KYVIPFHNYCKOMQ-YMRJDYICSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(3r,6r)-2-hydroxy-6-[(3s,8s,9r,10r,11r,13r,14s,17r)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYVIPFHNYCKOMQ-YMRJDYICSA-N 0.000 description 1
• NEZJDVYDSZTRFS-ZIQFBCGOSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-phenoxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-ZIQFBCGOSA-N 0.000 description 1
• IFBHRQDFSNCLOZ-GCHJQGSQSA-N (2r,3s,4s,5s,6r)-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-GCHJQGSQSA-N 0.000 description 1
• RQPQHAKPXABTTP-FWRGRRDFSA-N (2s)-2-amino-3-(1,4-dihydroxy-2-oxoimidazolidin-4-yl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1(O)CN(O)C(O)=N1 RQPQHAKPXABTTP-FWRGRRDFSA-N 0.000 description 1
• WYUFTYLVLQZQNH-CBQIKETKSA-N (2s,3r,4s,5s,6r)-2-ethoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WYUFTYLVLQZQNH-CBQIKETKSA-N 0.000 description 1
• WWVKOCDDDWJQLC-MWQJAWBESA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-9-acetyloxy-4-formyl-8-hydroxy-8a-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2s,3 Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O WWVKOCDDDWJQLC-MWQJAWBESA-N 0.000 description 1
• RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 description 1
• BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
• KWILGNNWGSNMPA-ZCFIWIBFSA-N (3r)-8-hydroxy-3-methyl-3,4-dihydroisochromen-1-one Chemical compound C1=CC(O)=C2C(=O)O[C@H](C)CC2=C1 KWILGNNWGSNMPA-ZCFIWIBFSA-N 0.000 description 1
• OHBHGGYGWZIWCX-VCSRPQGHSA-N (3r,3as,6as,8r,9r,9as,9bs)-3,8-dihydroxy-3-(hydroxymethyl)-9-methyl-6-methylidene-4,5,6a,7,8,9,9a,9b-octahydro-3ah-azuleno[4,5-b]furan-2-one Chemical compound C([C@@H]1[C@@](O)(CO)C(=O)O[C@H]11)CC(=C)[C@@H]2[C@H]1[C@@H](C)[C@H](O)C2 OHBHGGYGWZIWCX-VCSRPQGHSA-N 0.000 description 1
• QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 description 1
• NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
• LILOLDYAQAFVGN-DFOQSZTGSA-N (3s,4r,4as)-4-ethenyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3h-pyrano[3,4-c]pyran-8-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O1 LILOLDYAQAFVGN-DFOQSZTGSA-N 0.000 description 1
• GVXYKYSNVDIKBN-TVRYDQIASA-N (3η,25r)-26-(β-d-glucopoyranosyloxy) -22-hydroxyfurost-5-en-3-yl-4-o-β-d-glucopyranosyl-β-d-galactopyranoside Chemical compound O([C@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)O[C@@H]1CC2=CCC3C4CC5OC([C@H](C5[C@@]4(C)CCC3[C@@]2(C)CC1)C)(O)CC[C@@H](C)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GVXYKYSNVDIKBN-TVRYDQIASA-N 0.000 description 1
• XKXZHTWOHXJEOL-UHFFFAOYSA-N (4R,5S,8S,9S,10S,13R)-16,17-Dihydroxykauran-19-oic acid beta-D-glucopyranosyl ester Natural products C1C(C(O)(CO)C2)CCC3C12CCC1C3(C)CCCC1(C)C(=O)OC1OC(CO)C(O)C(O)C1O XKXZHTWOHXJEOL-UHFFFAOYSA-N 0.000 description 1
• STKUCSFEBXPTAY-UHFFFAOYSA-N (8E)-nuezhenide Natural products CC=C1C(CC(=O)OCC2C(C(O)C(O)C(OCCC=3C=CC(O)=CC=3)O2)O)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O STKUCSFEBXPTAY-UHFFFAOYSA-N 0.000 description 1
• SRPHMISUTWFFKJ-UHFFFAOYSA-N (E)-2beta,16alpha,20,25-tetrahydroxy-9-methyl-19-nor-9beta,10alpha-lanosta-5,23-diene-3,11,22-trione Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)C=CC(C)(O)C)C(O)CC3(C)C1CC=C1C2CC(O)C(=O)C1(C)C SRPHMISUTWFFKJ-UHFFFAOYSA-N 0.000 description 1
• 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
• KWILGNNWGSNMPA-LURJTMIESA-N (R)-(-)-Mellein Natural products C1=CC(O)=C2C(=O)O[C@@H](C)CC2=C1 KWILGNNWGSNMPA-LURJTMIESA-N 0.000 description 1
• NVLTYOJHPBMILU-GMDXDWKASA-N (R)-4-hydroxymandelonitrile beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H](C#N)C1=CC=C(O)C=C1 NVLTYOJHPBMILU-GMDXDWKASA-N 0.000 description 1
• XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
• UZQVYLOFLQICCT-SCSAIBSYSA-N (R)-goitrin Chemical compound C=C[C@@H]1CNC(=S)O1 UZQVYLOFLQICCT-SCSAIBSYSA-N 0.000 description 1
• ZKSZEJFBGODIJW-GMDXDWKASA-N (R)-prunasin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H](C#N)C1=CC=CC=C1 ZKSZEJFBGODIJW-GMDXDWKASA-N 0.000 description 1
• NVLTYOJHPBMILU-YOVYLDAJSA-N (S)-4-hydroxymandelonitrile beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](C#N)C1=CC=C(O)C=C1 NVLTYOJHPBMILU-YOVYLDAJSA-N 0.000 description 1
• QFXOXDSHNXAFEY-SREVYHEPSA-N (Z)-4-Hydroxy-6-dodecenoic acid lactone Chemical compound CCCCC\C=C/CC1CCC(=O)O1 QFXOXDSHNXAFEY-SREVYHEPSA-N 0.000 description 1
• WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
• YDDUMTOHNYZQPO-UHFFFAOYSA-N 1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid Natural products OC1C(O)CC(C(O)=O)(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-UHFFFAOYSA-N 0.000 description 1
• JUHCRMVGMSHJSY-UHFFFAOYSA-N 1,4-dihydroxycyclohexa-2,4-diene-1-carboxylic acid Chemical compound OC(=O)C1(O)CC=C(O)C=C1 JUHCRMVGMSHJSY-UHFFFAOYSA-N 0.000 description 1
• WYUFTYLVLQZQNH-UHFFFAOYSA-N 1-Ethyl-D-galactoside Natural products CCOC1OC(CO)C(O)C(O)C1O WYUFTYLVLQZQNH-UHFFFAOYSA-N 0.000 description 1
• SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
• ADOBXTDBFNCOBN-UHFFFAOYSA-N 1-heptadecene Chemical compound CCCCCCCCCCCCCCCC=C ADOBXTDBFNCOBN-UHFFFAOYSA-N 0.000 description 1
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• JVYKIBAJVKEZSQ-DHGKCCLASA-N 13-Hydroxylupanine Natural products C1N(C(CCC2)=O)[C@H]2[C@H]2CN3CC[C@@H](O)C[C@@H]3[C@@H]1C2 JVYKIBAJVKEZSQ-DHGKCCLASA-N 0.000 description 1
• JVYKIBAJVKEZSQ-RKQHYHRCSA-N 13-hydroxylupanine Chemical compound C1N(C(CCC2)=O)[C@H]2[C@H]2CN3CC[C@H](O)C[C@@H]3[C@@H]1C2 JVYKIBAJVKEZSQ-RKQHYHRCSA-N 0.000 description 1
• KCMPCYSXYDCHLT-UHFFFAOYSA-N 1h-cyclopenta[b]azepin-8-one Chemical compound C1=CC=CNC2=C1C=CC2=O KCMPCYSXYDCHLT-UHFFFAOYSA-N 0.000 description 1
• BRRSNXCXLSVPFC-UHFFFAOYSA-N 2,3,4-Trihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 description 1
• ILPLRBRVDMHSCS-UHFFFAOYSA-N 2,3,6,7-Tetrahydro-7-methylcyclopent[b]azepin-8(1H)-one Chemical compound O=C1C(C)CC2=C1NCCC=C2 ILPLRBRVDMHSCS-UHFFFAOYSA-N 0.000 description 1
• DRBARRGCABOUIE-UHFFFAOYSA-N 2,3-dihydroxy-3-phenylprop-2-enoic acid Chemical compound OC(=O)C(O)=C(O)C1=CC=CC=C1 DRBARRGCABOUIE-UHFFFAOYSA-N 0.000 description 1
• UJGOHVJQLPCGMJ-UHFFFAOYSA-N 2,3-dipyrrolidin-1-ylcyclopent-2-en-1-one Chemical compound C1CCCN1C=1C(=O)CCC=1N1CCCC1 UJGOHVJQLPCGMJ-UHFFFAOYSA-N 0.000 description 1
• IAJBQAYHSQIQRE-UHFFFAOYSA-N 2,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(OC)=C(C=O)C=C1OC IAJBQAYHSQIQRE-UHFFFAOYSA-N 0.000 description 1
• NLBYRERHXBTBBR-UHFFFAOYSA-N 2,4-dihydroxyheptadec-16-enyl acetate Chemical compound CC(=O)OCC(O)CC(O)CCCCCCCCCCCC=C NLBYRERHXBTBBR-UHFFFAOYSA-N 0.000 description 1
• HICPSQHUQBAFIQ-UHFFFAOYSA-N 2,5-dihydroxy-5-methyl-3-piperidin-1-ylcyclopent-2-en-1-one Chemical compound O=C1C(C)(O)CC(N2CCCCC2)=C1O HICPSQHUQBAFIQ-UHFFFAOYSA-N 0.000 description 1
• LUDYBTNWCIXIMM-UHFFFAOYSA-N 2,5-dihydroxy-5-methyl-3-pyrrolidin-1-ylcyclopent-2-en-1-one Chemical compound O=C1C(C)(O)CC(N2CCCC2)=C1O LUDYBTNWCIXIMM-UHFFFAOYSA-N 0.000 description 1
• IMYAWDVGMAMZPE-UHFFFAOYSA-N 2-(3-hydroxy-4-methoxyphenyl)-1,3-benzodioxin-4-one Chemical compound C1=C(O)C(OC)=CC=C1C1OC2=CC=CC=C2C(=O)O1 IMYAWDVGMAMZPE-UHFFFAOYSA-N 0.000 description 1
• OTVWBLWXIXXGRE-UHFFFAOYSA-N 2-(3-hydroxy-4-methoxyphenyl)benzoic acid Chemical compound C1=C(O)C(OC)=CC=C1C1=CC=CC=C1C(O)=O OTVWBLWXIXXGRE-UHFFFAOYSA-N 0.000 description 1
• KAWOFQZCZFQCSH-UHFFFAOYSA-N 2-[4-(dimethylamino)benzoyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=CC=CC=C1C(O)=O KAWOFQZCZFQCSH-UHFFFAOYSA-N 0.000 description 1
• QBIFEYLZKPFJHE-ZDUSSCGKSA-N 2-[[(4-cyanoanilino)-[[(1s)-1-phenylethyl]amino]methylidene]amino]acetic acid Chemical compound N(/[C@@H](C)C=1C=CC=CC=1)=C(\NCC(O)=O)NC1=CC=C(C#N)C=C1 QBIFEYLZKPFJHE-ZDUSSCGKSA-N 0.000 description 1
• MCVCQDNCAFEFCF-UHFFFAOYSA-N 2-amino-3,4-dimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(N)=C1OC MCVCQDNCAFEFCF-UHFFFAOYSA-N 0.000 description 1
• ZQTPOMUMEJTURV-UHFFFAOYSA-N 2-butoxy-5-nitroaniline Chemical compound CCCCOC1=CC=C([N+]([O-])=O)C=C1N ZQTPOMUMEJTURV-UHFFFAOYSA-N 0.000 description 1
• AMMPGYPPRLWMLW-UHFFFAOYSA-N 2-ethoxy-5-nitroaniline Chemical compound CCOC1=CC=C([N+]([O-])=O)C=C1N AMMPGYPPRLWMLW-UHFFFAOYSA-N 0.000 description 1
• JKRIWPXSEMPTNP-UHFFFAOYSA-N 2-hydroxylaminobenzoic acid Chemical compound ONC1=CC=CC=C1C(O)=O JKRIWPXSEMPTNP-UHFFFAOYSA-N 0.000 description 1
• NIPDVSLAMPAWTP-UHFFFAOYSA-N 2-methoxy-5-nitroaniline Chemical compound COC1=CC=C([N+]([O-])=O)C=C1N NIPDVSLAMPAWTP-UHFFFAOYSA-N 0.000 description 1
• WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
• WVDUXAROXPYCEJ-UHFFFAOYSA-N 3-(3-hydroxy-4-methoxyphenyl)butanoic acid Chemical compound COC1=CC=C(C(C)CC(O)=O)C=C1O WVDUXAROXPYCEJ-UHFFFAOYSA-N 0.000 description 1
• CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
• MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
• XHQZJYCNDZAGLW-UHFFFAOYSA-N 3-methoxybenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1 XHQZJYCNDZAGLW-UHFFFAOYSA-N 0.000 description 1
• JGAOJLNNEDAEHY-UHFFFAOYSA-N 4-(2-carboxy-2-hydroxyethyl)sulfanylpiperidine-1-carboxylic acid Chemical compound OC(=O)C(O)CSC1CCN(C(O)=O)CC1 JGAOJLNNEDAEHY-UHFFFAOYSA-N 0.000 description 1
• VTIPIBIDDZPDAV-MROQNXINSA-N 4-(Prop-2-en-1-yl)decahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one Chemical compound C1N(C(CCC2)=O)[C@H]2[C@H]2CN[C@@H](CC=C)[C@H]1C2 VTIPIBIDDZPDAV-MROQNXINSA-N 0.000 description 1
• AAUJGTSNOHLCRY-UHFFFAOYSA-N 4-(aminomethyl)-2-hydroxybenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C(O)=C1 AAUJGTSNOHLCRY-UHFFFAOYSA-N 0.000 description 1
• 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 1
• GYFFKZTYYAFCTR-JUHZACGLSA-N 4-O-trans-caffeoylquinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-JUHZACGLSA-N 0.000 description 1
• 229940093681 4-coumaric acid Drugs 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 4-nitrophenyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 0.000 description 1
• IFBHRQDFSNCLOZ-RMPHRYRLSA-N 4-nitrophenyl beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-RMPHRYRLSA-N 0.000 description 1
• IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
• GYFFKZTYYAFCTR-UHFFFAOYSA-N 5-O-(6'-O-galloyl)-beta-D-glucopyranosylgentisic acid Natural products OC1CC(O)(C(O)=O)CC(O)C1OC(=O)C=CC1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-UHFFFAOYSA-N 0.000 description 1
• QSTDKKMEYYKWHS-UHFFFAOYSA-N 5-hydroxy-5-methyl-2,3-di(piperidin-1-yl)cyclopent-2-en-1-one Chemical compound C1CCCCN1C=1C(=O)C(C)(O)CC=1N1CCCCC1 QSTDKKMEYYKWHS-UHFFFAOYSA-N 0.000 description 1
• AQQYFYYRFLYWIQ-UHFFFAOYSA-N 5-hydroxy-5-methyl-2,3-dipyrrolidin-1-ylcyclopent-2-en-1-one Chemical compound C1CCCN1C=1C(=O)C(C)(O)CC=1N1CCCC1 AQQYFYYRFLYWIQ-UHFFFAOYSA-N 0.000 description 1
• SQSLZARCXRKCIB-UHFFFAOYSA-N 5-methyl-2,3-dipyrrolidin-1-ylcyclopent-2-en-1-one Chemical compound C1CCCN1C=1C(=O)C(C)CC=1N1CCCC1 SQSLZARCXRKCIB-UHFFFAOYSA-N 0.000 description 1
• 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
• CJHYXUPCGHKJOO-GUESNGNRSA-N Abrusoside A Natural products O=C(O)[C@]1(C)[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]23[C@H]1CC[C@H]1[C@@]4(C)[C@@](C)([C@H]([C@@H](C)[C@H]5OC(=O)C(C)=CC5)CC4)CC[C@@]21C3 CJHYXUPCGHKJOO-GUESNGNRSA-N 0.000 description 1
• INCULGNJNLRUCH-UHFFFAOYSA-N Abrusoside B Natural products OC1C(O)C(O)C(C(=O)OC)OC1OC1C(OC2C(C3CCC4C5(C)CCC(C5(C)CCC54CC53CC2)C(C)C2OC(=O)C(C)=CC2)(C)C(O)=O)OC(CO)C(O)C1O INCULGNJNLRUCH-UHFFFAOYSA-N 0.000 description 1
• NISBQKZXGCOUOU-UHFFFAOYSA-N Abrusoside C Natural products C1C=C(C)C(=O)OC1C(C)C(C1(CCC23C4)C)CCC1(C)C2CCC(C1(C)C(O)=O)C34CCC1OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NISBQKZXGCOUOU-UHFFFAOYSA-N 0.000 description 1
• PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
• BYXHQQCXAJARLQ-ZLUOBGJFSA-N Ala-Ala-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O BYXHQQCXAJARLQ-ZLUOBGJFSA-N 0.000 description 1
• LJTZPXOCBZRFBH-CIUDSAMLSA-N Ala-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N LJTZPXOCBZRFBH-CIUDSAMLSA-N 0.000 description 1
• HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
• PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
• 239000004377 Alitame Substances 0.000 description 1
• MBUAMMAQTSOCFA-UHFFFAOYSA-N Amaropanin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cccc(O)c4c5cccc(O)c5)C(O)C1O MBUAMMAQTSOCFA-UHFFFAOYSA-N 0.000 description 1
• UZYZCCWBBBCDAD-WCYQFIIKSA-N Amaroswerin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@]3(O)CCOC(=O)C3=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 UZYZCCWBBBCDAD-WCYQFIIKSA-N 0.000 description 1
• UZYZCCWBBBCDAD-UHFFFAOYSA-N Amaroswerin Natural products OC1C(O)C(CO)OC(OC2C(C3(O)CCOC(=O)C3=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 UZYZCCWBBBCDAD-UHFFFAOYSA-N 0.000 description 1
• 241000609240 Ambelania acida Species 0.000 description 1
• VTIPIBIDDZPDAV-FDYHWXHSSA-N Angustifoline Natural products O=C1N2[C@@H]([C@H]3CN[C@H](CC=C)[C@@H](C2)C3)CCC1 VTIPIBIDDZPDAV-FDYHWXHSSA-N 0.000 description 1
• JEXPNDORFYHJTM-IHRRRGAJSA-N Arg-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCN=C(N)N JEXPNDORFYHJTM-IHRRRGAJSA-N 0.000 description 1
• LQJAALCCPOTJGB-YUMQZZPRSA-N Arg-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O LQJAALCCPOTJGB-YUMQZZPRSA-N 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• FRYULLIZUDQONW-UHFFFAOYSA-N Aspartyl-Aspartate Chemical compound OC(=O)CC(N)C(=O)NC(CC(O)=O)C(O)=O FRYULLIZUDQONW-UHFFFAOYSA-N 0.000 description 1
• 229930003347 Atropine Natural products 0.000 description 1
• 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
• UHWXBWBOPABGIG-XRSBSPCNSA-N Carnosifloside III Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OCC(/C)=C/CC[C@@H](C)[C@@H]1[C@]2(CC(=O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UHWXBWBOPABGIG-XRSBSPCNSA-N 0.000 description 1
• 239000004380 Cholic acid Substances 0.000 description 1
• WNBCMONIPIJTSB-TVKJYDDYSA-N Cichoriin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1C=CC(=O)O2 WNBCMONIPIJTSB-TVKJYDDYSA-N 0.000 description 1
• 235000001258 Cinchona calisaya Nutrition 0.000 description 1
• WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
• DRSITEVYZGOOQG-UHFFFAOYSA-N Cohumulone Chemical compound CC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C(O)(CC=C(C)C)C1=O DRSITEVYZGOOQG-UHFFFAOYSA-N 0.000 description 1
• DRSITEVYZGOOQG-HXUWFJFHSA-N Cohumulone Natural products CC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@](O)(CC=C(C)C)C1=O DRSITEVYZGOOQG-HXUWFJFHSA-N 0.000 description 1
• IHTCCHVMPGDDSL-ZJNDIJRCSA-N Cucurbitacin A Natural products O=C([C@@](O)(C)[C@H]1[C@@H](O)C[C@]2(C)[C@]1(C)CC(=O)[C@]1(CO)[C@H]2CC=C2C(C)(C)C(=O)[C@H](O)C[C@@H]12)/C=C/C(OC(=O)C)(C)C IHTCCHVMPGDDSL-ZJNDIJRCSA-N 0.000 description 1
• CVKKIVYBGGDJCR-SXDZHWHFSA-N Cucurbitacin B Natural products CC(=O)OC(C)(C)C=CC(=O)[C@@](C)(O)[C@@H]1[C@@H](O)C[C@]2(C)C3=CC[C@@H]4C(C)(C)C(=O)[C@H](O)C[C@@]4(C)[C@@H]3CC(=O)[C@@]12C CVKKIVYBGGDJCR-SXDZHWHFSA-N 0.000 description 1
• UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
• OHBHGGYGWZIWCX-DEJOPHEWSA-N Cynaratriol Natural products O=C1[C@](O)(CO)[C@H]2[C@@H](O1)[C@H]1[C@H](C)[C@@H](O)C[C@H]1C(=C)CC2 OHBHGGYGWZIWCX-DEJOPHEWSA-N 0.000 description 1
• SITQVDJAXQSXSA-CEZRHVESSA-N Cynarin Natural products O[C@@H]1C[C@@](C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)(OC(=O)C=Cc3cccc(O)c3O)C(=O)O SITQVDJAXQSXSA-CEZRHVESSA-N 0.000 description 1
• YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 1
• KHSCYOFDKADJDJ-NQLMQOPMSA-N Cynaropicrin Chemical compound OCC(=C)C(=O)O[C@H]1CC(=C)[C@@H]2C[C@H](O)C(=C)[C@@H]2[C@H]2OC(=O)C(=C)[C@H]12 KHSCYOFDKADJDJ-NQLMQOPMSA-N 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
• KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
• UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• NVLTYOJHPBMILU-JAYDOHCTSA-N Dhurrin Natural products O([C@@H](C#N)c1ccc(O)cc1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 NVLTYOJHPBMILU-JAYDOHCTSA-N 0.000 description 1
• 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
• QZJJDOYZVRUEDY-UHFFFAOYSA-N Dihydrocucurbitacin B Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)CCC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C1C2CC(O)C(=O)C1(C)C QZJJDOYZVRUEDY-UHFFFAOYSA-N 0.000 description 1
• CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 description 1
• CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 description 1
• LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 239000004386 Erythritol Substances 0.000 description 1
• UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
• 101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 1
• SASRTFVIQCGADD-UHFFFAOYSA-N Eustomoside Natural products OCC1OC(OC2OC=C3C(=O)OCCC3(O)C2C4CO4)C(O)C(O)C1O SASRTFVIQCGADD-UHFFFAOYSA-N 0.000 description 1
• 239000001183 FEMA 4495 Substances 0.000 description 1
• 239000001512 FEMA 4601 Substances 0.000 description 1
• 239000001689 FEMA 4674 Substances 0.000 description 1
• WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
• ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
• CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
• SOYHWVFJWINWIL-UHFFFAOYSA-N Gentomoside Natural products CC(=O)OCC1OC(OC2OC=C3C(=O)OCCC3(O)C2C4CO4)C(OC(=O)C)C(OC(=O)C)C1OC(=O)c5cccc(OC6OC(CO)C(O)C(O)C6O)c5O SOYHWVFJWINWIL-UHFFFAOYSA-N 0.000 description 1
• 108091006101 Gi proteins Proteins 0.000 description 1
• 102000034354 Gi proteins Human genes 0.000 description 1
• TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 description 1
• BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• UZQVYLOFLQICCT-UHFFFAOYSA-N Goitrin Natural products C=CC1CNC(=S)O1 UZQVYLOFLQICCT-UHFFFAOYSA-N 0.000 description 1
• GEIBYCLALAGPDY-UHFFFAOYSA-N Grosshemina Natural products CC1C2CC(O)C(=C)C3C(C2OC1=O)C(=C)CC3=O GEIBYCLALAGPDY-UHFFFAOYSA-N 0.000 description 1
• BLBIUXNCYVEVPT-UHFFFAOYSA-N Gymnenmasaponin IV Natural products OC1CC(C2(CCC3C(C)(COC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)C(O)CCC3(C)C2CC=2)C)(C)C=2C2CC(C)(C)CCC21COC1OC(CO)C(O)C(O)C1O BLBIUXNCYVEVPT-UHFFFAOYSA-N 0.000 description 1
• HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 description 1
• HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 description 1
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000659765 Homo sapiens Taste receptor type 1 member 2 Proteins 0.000 description 1
• 101000659774 Homo sapiens Taste receptor type 1 member 3 Proteins 0.000 description 1
• 101000674775 Homo sapiens Taste receptor type 2 member 16 Proteins 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• RMFGNMMNUZWCRZ-UHFFFAOYSA-N Humulone Natural products CC(C)CC(=O)C1=C(O)C(O)(CC=C(C)C)C(O)=C(CC=C(C)C)C1=O RMFGNMMNUZWCRZ-UHFFFAOYSA-N 0.000 description 1
• LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
• RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
• GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 description 1
• 108090000862 Ion Channels Proteins 0.000 description 1
• 102000004310 Ion Channels Human genes 0.000 description 1
• LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
• 229930193815 Isohumulone Natural products 0.000 description 1
• QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
• XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 235000019454 L-leucine Nutrition 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
• WEWBWVMTOYUPHH-HQPKYVJOSA-N Lotaustralin Natural products O([C@@](C#N)(CC)C)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 WEWBWVMTOYUPHH-HQPKYVJOSA-N 0.000 description 1
• WEWBWVMTOYUPHH-QHAQEBJBSA-N Lotaustralin Chemical compound CC[C@](C)(C#N)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WEWBWVMTOYUPHH-QHAQEBJBSA-N 0.000 description 1
• 241000219745 Lupinus Species 0.000 description 1
• OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 101710084933 Miraculin Proteins 0.000 description 1
• WVXIMWMLKSCVTD-JLRHFDOOSA-N Mogroside II-E Chemical compound O([C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WVXIMWMLKSCVTD-JLRHFDOOSA-N 0.000 description 1
• KYVIPFHNYCKOMQ-UHFFFAOYSA-N Mogroside III Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O KYVIPFHNYCKOMQ-UHFFFAOYSA-N 0.000 description 1
• 108050004114 Monellin Proteins 0.000 description 1
• ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
• KJDQCOYWEHFUPI-FVGYRXGTSA-N N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O.NC1(CCCC1)C(=O)O Chemical compound N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O.NC1(CCCC1)C(=O)O KJDQCOYWEHFUPI-FVGYRXGTSA-N 0.000 description 1
• CWBZAESOUBENAP-QVNVHUMTSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@H](CO)[C@@H](O)[C@@H]1O CWBZAESOUBENAP-QVNVHUMTSA-N 0.000 description 1
• CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
• 239000004384 Neotame Substances 0.000 description 1
• IMKJGXCIJJXALX-SHUKQUCYSA-N Norambreinolide Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@]2(C)OC(=O)C1 IMKJGXCIJJXALX-SHUKQUCYSA-N 0.000 description 1
• JQISCPCCMUMVON-UHFFFAOYSA-N Oc1cccc(CCc2cc(O)c(O)c(Oc3ccc(CCc4cccc(O)c4O)cc3)c2)c1 Chemical compound Oc1cccc(CCc2cc(O)c(O)c(Oc3ccc(CCc4cccc(O)c4O)cc3)c2)c1 JQISCPCCMUMVON-UHFFFAOYSA-N 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 description 1
• YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 108010067902 Peptide Library Proteins 0.000 description 1
• KYZGSVXLJRVXSE-UHFFFAOYSA-N Periandrin IV Natural products CC1(C)C(CCC2(CO)C1CCC3(C)C2CC=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(C(O)C(O)C7O)C(=O)O)C(=O)O KYZGSVXLJRVXSE-UHFFFAOYSA-N 0.000 description 1
• XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
• IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 description 1
• 229940126902 Phlorizin Drugs 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• KWILGNNWGSNMPA-UHFFFAOYSA-N R-mellein Natural products C1=CC(O)=C2C(=O)OC(C)CC2=C1 KWILGNNWGSNMPA-UHFFFAOYSA-N 0.000 description 1
• 101000633010 Rattus norvegicus Somatostatin Proteins 0.000 description 1
• HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
• XINNQYBYFFJBAM-OBOKACSWSA-N Rindoside Chemical compound O([C@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](O[C@H]2[C@@H]([C@]3(O)CCOC(=O)C3=CO2)C=C)O[C@@H]1COC(=O)C)C(=O)C(C=1O)=CC=CC=1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XINNQYBYFFJBAM-OBOKACSWSA-N 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 1
• 240000000111 Saccharum officinarum Species 0.000 description 1
• 235000007201 Saccharum officinarum Nutrition 0.000 description 1
• ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 108010073771 Soybean Proteins Proteins 0.000 description 1
• 101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 1
• ZIJKGAXBCRWEOL-SAXBRCJISA-N Sucrose octaacetate Chemical compound CC(=O)O[C@H]1[C@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1 ZIJKGAXBCRWEOL-SAXBRCJISA-N 0.000 description 1
• VSJGJMKGNMDJCI-ZASXJUAOSA-N Sweroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@H](CCOC2=O)C2=CO1 VSJGJMKGNMDJCI-ZASXJUAOSA-N 0.000 description 1
• 102100035948 Taste receptor type 1 member 2 Human genes 0.000 description 1
• 102100040649 Taste receptor type 2 member 10 Human genes 0.000 description 1
• 102100021234 Taste receptor type 2 member 16 Human genes 0.000 description 1
• SSOALNRVRBIEME-UHFFFAOYSA-N Theasaponin E1 Natural products CC=C(C)/C(=O)OC1C(OC(=O)C)C2(CO)C(O)CC3(C)C(=CCC4C5(C)CCC(OC6OC(C(O)C(OC7OC(O)C(O)CC7OC8OCC(O)C(O)C8O)C6OC9OC(CO)C(O)C(O)C9O)C(=O)O)C(C)(C=O)C5CCC34C)C2CC1(C)C SSOALNRVRBIEME-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• XYNPYHXGMWJBLV-VXPJTDKGSA-N Tomatidine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@@]11CC[C@H](C)CN1 XYNPYHXGMWJBLV-VXPJTDKGSA-N 0.000 description 1
• QMGSCYSTMWRURP-UHFFFAOYSA-N Tomatine Natural products CC1CCC2(NC1)OC3CC4C5CCC6CC(CCC6(C)C5CCC4(C)C3C2C)OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(O)C%10O)C8O)C(O)C7O QMGSCYSTMWRURP-UHFFFAOYSA-N 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• RMBMLYUFYBZPCX-DZPSSIEHSA-N Trifloroside Natural products O=C(OC[C@H]1[C@@H](OC(=O)c2c(O)c(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)ccc2)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@H](O[C@H]2[C@@H](C=C)[C@H]3C(C(=O)OCC3)=CO2)O1)C RMBMLYUFYBZPCX-DZPSSIEHSA-N 0.000 description 1
• LVTJOONKWUXEFR-YFQJTNJMSA-N Trigonelloside C Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@]([C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)(O)CC[C@H](C)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O LVTJOONKWUXEFR-YFQJTNJMSA-N 0.000 description 1
• 229930182647 Trilobatin Natural products 0.000 description 1
• 241000209140 Triticum Species 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
• SPFBVQWRJFUDBB-FYBFSNJASA-N Ziziphin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2C([C@H]3[C@]([C@@H]4[C@@]([C@@]56C[C@]7([C@H]([C@@](C[C@@H](O7)C=C(C)C)(C)O[C@H]7[C@@H]([C@H](OC(C)=O)[C@@H](O)[C@H](C)O7)OC(C)=O)[C@H]6CC4)OC5)(C)CC3)(C)CC2)(C)C)OC1 SPFBVQWRJFUDBB-FYBFSNJASA-N 0.000 description 1
• QLVJDGJNRIPOSF-UHFFFAOYSA-N Ziziphin Natural products CC1OC(COCC2COC(COC3CCC4(C)C(CCC5(C)C4CCC6C7C(C)(CC(OC78CC56CO8)C=C(C)C)OC9OC(C)C(O)C(OC(=O)C)C9OC(=O)C)C3(C)C)C(O)C2O)C(O)C(O)C1O QLVJDGJNRIPOSF-UHFFFAOYSA-N 0.000 description 1
• MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 1
• 239000001344 [(2S,3S,4R,5R)-4-acetyloxy-2,5-bis(acetyloxymethyl)-2-[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxolan-3-yl] acetate Substances 0.000 description 1
• KOVJNHVDYMZQCP-WEWAHAGASA-N [(2r,3s,4s,5s,6s)-2-[(4-ethenyl-8-oxo-4,4a,5,6-tetrahydro-3h-pyrano[3,4-c]pyran-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2-hydroxy-6-(3-hydroxyphenyl)benzoate Chemical compound O([C@@H]1[C@@H](OC2C(C3C(C(OCC3)=O)=CO2)C=C)O[C@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=CC=C1C1=CC=CC(O)=C1 KOVJNHVDYMZQCP-WEWAHAGASA-N 0.000 description 1
• NKAYJMFKKMUJQU-ZFIFBBNOSA-N [(2s,3r,4r,5r)-3,4-dihydroxy-5-[[(10r,12s,14r)-17-[(2s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,7,10,14-pentamethyl-12-[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanth Chemical compound O([C@H]1CC2[C@@]3(C)CCC(C(C)(C)C3CC(C2[C@@]2(C)CCC(C21)[C@@]1(C)OC(CC1)C(C)(C)O)C)O[C@H]1[C@@H]([C@@H](O)[C@H](COC(C)=O)O1)O)[C@@H]1O[C@@H](C)[C@H](O)[C@H](O)[C@H]1O NKAYJMFKKMUJQU-ZFIFBBNOSA-N 0.000 description 1
• UBRMQRLIHZXASZ-UHFFFAOYSA-N [K].OC1=CC(OCC[CH2])=CC(O)=C1C(=O)CCC1=CC=C(OC)C(O)=C1 Chemical class [K].OC1=CC(OCC[CH2])=CC(O)=C1C(=O)CCC1=CC=C(OC)C(O)=C1 UBRMQRLIHZXASZ-UHFFFAOYSA-N 0.000 description 1
• QGKAVFXNTADNHB-UHFFFAOYSA-N [Mg].[K].[Ca] Chemical compound [Mg].[K].[Ca] QGKAVFXNTADNHB-UHFFFAOYSA-N 0.000 description 1
• KGHMYJFHUHFOGL-UHFFFAOYSA-N [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid Chemical compound C=1C=C(C#N)C=CC=1NC(=N/CC(=O)O)\NC(C=1C=CC=CC=1)C1=CC=CC=C1 KGHMYJFHUHFOGL-UHFFFAOYSA-N 0.000 description 1
• HMQKXUDOQSFWTG-UHFFFAOYSA-N abrusodide D Natural products CC(C1CC=C(C)C(=O)O1)C2CCC3(C)C4CCC5C(C)(C(CCC56CC46CCC23C)OC7OC(C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(=O)O)C(=O)O HMQKXUDOQSFWTG-UHFFFAOYSA-N 0.000 description 1
• CJHYXUPCGHKJOO-AYOTXDKCSA-N abrusoside A Chemical compound O([C@H]1CC[C@@]23[C@H]([C@]1(C)C(O)=O)CC[C@H]1[C@]4(C)CC[C@@H]([C@]4(CC[C@]12C3)C)[C@H](C)[C@H]1OC(=O)C(C)=CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CJHYXUPCGHKJOO-AYOTXDKCSA-N 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• QOMNQGZXFYNBNG-UHFFFAOYSA-N acetyloxymethyl 2-[2-[2-[5-[3-(acetyloxymethoxy)-2,7-difluoro-6-oxoxanthen-9-yl]-2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]phenoxy]ethoxy]-n-[2-(acetyloxymethoxy)-2-oxoethyl]-4-methylanilino]acetate Chemical compound CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=CC=C(C)C=C1OCCOC1=CC(C2=C3C=C(F)C(=O)C=C3OC3=CC(OCOC(C)=O)=C(F)C=C32)=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O QOMNQGZXFYNBNG-UHFFFAOYSA-N 0.000 description 1
• 229940091181 aconitic acid Drugs 0.000 description 1
• 229930185474 acteoside Natural products 0.000 description 1
• FBSKJMQYURKNSU-ZLSOWSIRSA-N acteoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FBSKJMQYURKNSU-ZLSOWSIRSA-N 0.000 description 1
• FBSKJMQYURKNSU-UKQWSTALSA-N acteoside I Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)C=Cc4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O FBSKJMQYURKNSU-UKQWSTALSA-N 0.000 description 1
• QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 108010009985 alitame Proteins 0.000 description 1
• 235000019409 alitame Nutrition 0.000 description 1
• JYIJIIVLEOETIQ-UHFFFAOYSA-N alpha-Isolupanin Natural products C12CCCCN2CC2C3CCCC(=O)N3CC1C2 JYIJIIVLEOETIQ-UHFFFAOYSA-N 0.000 description 1
• QLTCHMYAEJEXBT-UHFFFAOYSA-N alpha-beta-D-glucopyranosyloxy-isobutyronitrile Natural products N#CC(C)(C)OC1OC(CO)C(O)C(O)C1O QLTCHMYAEJEXBT-UHFFFAOYSA-N 0.000 description 1
• KXSHCOVQRKPAEU-UHFFFAOYSA-N alpha-chaconine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(C)C(O)C(O)C8O)C7OC9OC(C)C(O)C(O)C9O)N2C1 KXSHCOVQRKPAEU-UHFFFAOYSA-N 0.000 description 1
• SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
• RXVGBQCEAQZMLW-UHFFFAOYSA-N alpha-solanine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7OC9OC(CO)C(O)C(O)C9O)N2C1 RXVGBQCEAQZMLW-UHFFFAOYSA-N 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
• 229940089837 amygdalin Drugs 0.000 description 1
• JJBNDYFPSDEMBS-UHFFFAOYSA-N angustifolin Natural products COC1OCC2(C)CCCC3(COC(=O)C4C3C(O)CC(=C)C4=O)C12 JJBNDYFPSDEMBS-UHFFFAOYSA-N 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 108010060035 arginylproline Proteins 0.000 description 1
• DNAVOCNYHNNEQI-UHFFFAOYSA-N asaronaldehyde Natural products COC1=CC(OC)=C(C=CC=O)C=C1OC DNAVOCNYHNNEQI-UHFFFAOYSA-N 0.000 description 1
• 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
• NEDXBOYHFHZBAP-UHFFFAOYSA-N assamsaponin D Natural products CC=C(C)/C(=O)OC1C(OC(=O)C)C2(CO)C(O)CC3(C)C(=CCC4C5(C)CCC(OC6OC(C(O)C(OC7OC(O)C(O)CC7OC8OCC(O)C(O)C8O)C6OC9OC(CO)C(O)C(O)C9O)C(=O)O)C(C)(CO)C5CCC34C)C2CC1(C)C NEDXBOYHFHZBAP-UHFFFAOYSA-N 0.000 description 1
• RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
• 229960000396 atropine Drugs 0.000 description 1
• XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
• 239000010905 bagasse Substances 0.000 description 1
• JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical compound C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• GKHCBYYBLTXYEV-UJPOAAIJSA-N benzyl beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCC1=CC=CC=C1 GKHCBYYBLTXYEV-UJPOAAIJSA-N 0.000 description 1
• DMRHOZBCVOAFHR-UHFFFAOYSA-N benzyl-[2-(2,6-dimethylanilino)-2-oxoethyl]-diethylazanium 1-oxido-1-oxo-1,2-benzothiazol-3-one Chemical compound CC[N+](CC)(CC1=CC=CC=C1)CC(=O)NC2=C(C=CC=C2C)C.C1=CC=C2C(=C1)C(=O)N=S2(=O)[O-] DMRHOZBCVOAFHR-UHFFFAOYSA-N 0.000 description 1
• WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 229940074360 caffeic acid Drugs 0.000 description 1
• 229960001948 caffeine Drugs 0.000 description 1
• VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• IQNLJIQMOCLZJG-UHFFFAOYSA-N carboxy benzoate Chemical compound OC(=O)OC(=O)C1=CC=CC=C1 IQNLJIQMOCLZJG-UHFFFAOYSA-N 0.000 description 1
• DPAJZQDHFKAPSC-UHFFFAOYSA-N carnosifloside V Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC=C(C)COC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O DPAJZQDHFKAPSC-UHFFFAOYSA-N 0.000 description 1
• ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
• 235000005487 catechin Nutrition 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• INCULGNJNLRUCH-IVXQMWAOSA-N chembl489990 Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C(=O)OC)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@@]([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)[C@H]2OC(=O)C(C)=CC2)(C)C(O)=O)O[C@H](CO)[C@@H](O)[C@@H]1O INCULGNJNLRUCH-IVXQMWAOSA-N 0.000 description 1
• KLBQQJXKVACGIQ-DMBDAVFKSA-N chembl500346 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@@]23[C@H]([C@]1(C)C(O)=O)CC[C@H]1[C@]4(C)CC[C@@H]([C@]4(CC[C@]12C3)C)[C@H](C)[C@H]1OC(=O)C(C)=CC1)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O KLBQQJXKVACGIQ-DMBDAVFKSA-N 0.000 description 1
• NISBQKZXGCOUOU-UNEPLQKGSA-N chembl503532 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@@]23[C@H]([C@]1(C)C(O)=O)CC[C@H]1[C@]4(C)CC[C@@H]([C@]4(CC[C@]12C3)C)[C@H](C)[C@H]1OC(=O)C(C)=CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NISBQKZXGCOUOU-UNEPLQKGSA-N 0.000 description 1
• 230000002925 chemical effect Effects 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 230000000723 chemosensory effect Effects 0.000 description 1
• 229940074393 chlorogenic acid Drugs 0.000 description 1
• 235000001368 chlorogenic acid Nutrition 0.000 description 1
• CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
• FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
• 229960002471 cholic acid Drugs 0.000 description 1
• BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
• 235000019416 cholic acid Nutrition 0.000 description 1
• 238000011210 chromatographic step Methods 0.000 description 1
• 229950001002 cianidanol Drugs 0.000 description 1
• 235000013985 cinnamic acid Nutrition 0.000 description 1
• 229930016911 cinnamic acid Natural products 0.000 description 1
• BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229940109239 creatinine Drugs 0.000 description 1
• GYFFKZTYYAFCTR-LMRQPLJMSA-N cryptochlorogenic acid Natural products O[C@H]1C[C@@](O)(C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O GYFFKZTYYAFCTR-LMRQPLJMSA-N 0.000 description 1
• JTPLNLNCNOCZIB-UHFFFAOYSA-N cucurbitacin D Natural products CC(C)(O)C=CC(=O)C(C)(O)C1C(O)CC2C3CC=C4C(C)(C)C(=O)C(O)CC4(C)C3C(=O)CC12C JTPLNLNCNOCZIB-UHFFFAOYSA-N 0.000 description 1
• 108010010165 curculin Proteins 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 229930193831 cyclocarioside Natural products 0.000 description 1
• 229950009125 cynarine Drugs 0.000 description 1
• YDDUMTOHNYZQPO-BKUKFAEQSA-N cynarine Natural products O[C@H]1C[C@@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-BKUKFAEQSA-N 0.000 description 1
• STQKFHDZSADKCG-UHFFFAOYSA-N cynaropicrin Natural products OC1CC2C(C3OC(=O)C(=C)C3C(CC2=C)OC(=O)C(=C)O)C1=C STQKFHDZSADKCG-UHFFFAOYSA-N 0.000 description 1
• 235000007240 daidzein Nutrition 0.000 description 1
• KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
• KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
• 238000000586 desensitisation Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• SIUKXCMDYPYCLH-UHFFFAOYSA-N dihydroxycinnamic acid Natural products OC(=O)C=CC1=CC=CC(O)=C1O SIUKXCMDYPYCLH-UHFFFAOYSA-N 0.000 description 1
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
• 229940090949 docosahexaenoic acid Drugs 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• IMKJGXCIJJXALX-UHFFFAOYSA-N ent-Norambreinolide Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C)OC(=O)C2 IMKJGXCIJJXALX-UHFFFAOYSA-N 0.000 description 1
• HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
• LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
• 235000012734 epicatechin Nutrition 0.000 description 1
• DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
• 229940030275 epigallocatechin gallate Drugs 0.000 description 1
• 210000002409 epiglottis Anatomy 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 230000003628 erosive effect Effects 0.000 description 1
• 235000019414 erythritol Nutrition 0.000 description 1
• 229940009714 erythritol Drugs 0.000 description 1
• UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
• ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
• 229940093496 esculin Drugs 0.000 description 1
• XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
• AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 229940093503 ethyl maltol Drugs 0.000 description 1
• YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 238000012632 fluorescent imaging Methods 0.000 description 1
• 230000004907 flux Effects 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 229940074391 gallic acid Drugs 0.000 description 1
• 235000004515 gallic acid Nutrition 0.000 description 1
• 238000012215 gene cloning Methods 0.000 description 1
• 229940045109 genistein Drugs 0.000 description 1
• 235000006539 genistein Nutrition 0.000 description 1
• TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
• 229960005219 gentisic acid Drugs 0.000 description 1
• SGQJDTLFQCDZGS-UHFFFAOYSA-N geshoidin Natural products OC1C(O)C(O)C(CO)OC1OC(C1=C2O)=CC=CC1=CC1=C2C(=O)OC1 SGQJDTLFQCDZGS-UHFFFAOYSA-N 0.000 description 1
• 239000006481 glucose medium Substances 0.000 description 1
• 229930182478 glucoside Natural products 0.000 description 1
• 150000008131 glucosides Chemical class 0.000 description 1
• 229940049906 glutamate Drugs 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 229960002989 glutamic acid Drugs 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 108010050848 glycylleucine Proteins 0.000 description 1
• LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
• 229940070818 glycyrrhizate Drugs 0.000 description 1
• 239000001685 glycyrrhizic acid Substances 0.000 description 1
• 229960004949 glycyrrhizic acid Drugs 0.000 description 1
• UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
• 235000019410 glycyrrhizin Nutrition 0.000 description 1
• 229940074774 glycyrrhizinate Drugs 0.000 description 1
• GOERTRUXQHDLHC-UHFFFAOYSA-N gramine Natural products COC1=CC=C2NC=C(CN(C)C)C2=C1 GOERTRUXQHDLHC-UHFFFAOYSA-N 0.000 description 1
• ICYOLCFDSJJLAC-UHFFFAOYSA-N gramine Chemical compound C1=CC=C[C]2C(CN(C)C)=CN=C21 ICYOLCFDSJJLAC-UHFFFAOYSA-N 0.000 description 1
• YGMIBVIKXJJQQJ-UHFFFAOYSA-N grosshemin guaianolide Natural products OC1CC(=C)C2CC(=O)C(C)C2C2OC(=O)C(=C)C21 YGMIBVIKXJJQQJ-UHFFFAOYSA-N 0.000 description 1
• 229930190118 gymnemasaponin Natural products 0.000 description 1
• UTXXLDCMCDLEDQ-UHFFFAOYSA-N gymnemasaponin V Natural products CC1(C)CCC2(C)C(CC3(C)C(=CCC4C5(C)CCC(O)C(C)(COC6OC(COC7OC(CO)C(O)C(O)C7O)C(O)C(O)C6O)C5CCC34C)C2C1)OOC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O UTXXLDCMCDLEDQ-UHFFFAOYSA-N 0.000 description 1
• BGOFCVIGEYGEOF-UJPOAAIJSA-N helicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1C=O BGOFCVIGEYGEOF-UJPOAAIJSA-N 0.000 description 1
• 229940068628 helicin Drugs 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 238000012203 high throughput assay Methods 0.000 description 1
• 238000013537 high throughput screening Methods 0.000 description 1
• DPMKYRJUMRDZSZ-UHFFFAOYSA-N hoduloside I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C3C(C4C(C5(CC(=O)OC5)C(C5C(O5)(C)CC(OC5C(C(O)C(O)C(CO)O5)O)C=C(C)C)CC4)(C)CC3)(C)CC2)(C)C)OC(CO)C(O)C1O DPMKYRJUMRDZSZ-UHFFFAOYSA-N 0.000 description 1
• 230000001632 homeopathic effect Effects 0.000 description 1
• 229930185661 huangqioside Natural products 0.000 description 1
• 102000056291 human TAS2R10 Human genes 0.000 description 1
• VMSLCPKYRPDHLN-NRFANRHFSA-N humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@@](O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-NRFANRHFSA-N 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 235000013902 inosinic acid Nutrition 0.000 description 1
• 239000004245 inosinic acid Substances 0.000 description 1
• 229940028843 inosinic acid Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• QARXXMMQVDCYGZ-UHFFFAOYSA-N isohumulone Chemical compound CC(C)CC(=O)C1=C(O)C(O)(C(=O)CC=C(C)C)C(CC=C(C)C)C1=O QARXXMMQVDCYGZ-UHFFFAOYSA-N 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 239000000905 isomalt Substances 0.000 description 1
• 235000010439 isomalt Nutrition 0.000 description 1
• HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
• KSSMBFYXDHYVTA-UHFFFAOYSA-N jujubasaponin II Natural products CC1OC(OC2C(O)C(O)COC2OC3CCC4(C)C(CCC5(C)C4CCC6C7C(C)(CC(OC78CC56CO8)C=C(C)C)OC9OC(C)C(O)C(O)C9OC(=O)C)C3(C)C)C(O)C(O)C1O KSSMBFYXDHYVTA-UHFFFAOYSA-N 0.000 description 1
• SAGRVOQCXUNTMM-UHFFFAOYSA-N jujubasaponin III Natural products CC1OC(OC2C(O)C(O)COC2OC3CCC4(C)C(CCC5(C)C4CCC6C7C(C)(CC(OC78CC56CO8)C=C(C)C)OC9OC(C)C(O)C(OC(=O)C)C9O)C3(C)C)C(O)C(O)C1O SAGRVOQCXUNTMM-UHFFFAOYSA-N 0.000 description 1
• 235000008777 kaempferol Nutrition 0.000 description 1
• BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
• HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
• 239000000832 lactitol Substances 0.000 description 1
• 235000010448 lactitol Nutrition 0.000 description 1
• VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
• 229960003451 lactitol Drugs 0.000 description 1
• 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
• KFKWRHQBZQICHA-UHFFFAOYSA-N leucyl-phenylalanine Chemical compound CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-UHFFFAOYSA-N 0.000 description 1
• CRTWQTRFSBJGLK-UHFFFAOYSA-N linamarin Natural products CC(C)(C#N)C1OC(CO)C(O)C(O)C1O CRTWQTRFSBJGLK-UHFFFAOYSA-N 0.000 description 1
• QLTCHMYAEJEXBT-ZEBDFXRSSA-N linamarin Chemical compound N#CC(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QLTCHMYAEJEXBT-ZEBDFXRSSA-N 0.000 description 1
• 239000013554 lipid monolayer Substances 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• JYIJIIVLEOETIQ-XDQVBPFNSA-N lupanine Chemical compound C([C@H]12)CCCN1C[C@H]1[C@H]3CCCC(=O)N3C[C@@H]2C1 JYIJIIVLEOETIQ-XDQVBPFNSA-N 0.000 description 1
• PXSNOBCUERDYST-UHFFFAOYSA-N lupanine Natural products O=C1CCCN2CC3CC(CC12)N4CCCCC34 PXSNOBCUERDYST-UHFFFAOYSA-N 0.000 description 1
• LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 239000000845 maltitol Substances 0.000 description 1
• 235000010449 maltitol Nutrition 0.000 description 1
• VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
• 229940035436 maltitol Drugs 0.000 description 1
• 229940043353 maltol Drugs 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• ZTQOIDSGZDUGJX-SSDOTTSWSA-N mellein Natural products C[C@H]1CC(=O)c2c(O)cccc2C1 ZTQOIDSGZDUGJX-SSDOTTSWSA-N 0.000 description 1
• HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• MFZDFMOKBMJUGB-CWERYYTKSA-N methyl (5e,6s)-5-ethylidene-4-[2-[[(2r,3s,4s,5r,6r)-5-[2-[(2s,3e)-3-ethylidene-5-methoxycarbonyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4h-pyran-4-yl]acetyl]oxy-3,4-dihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-2-o Chemical compound O([C@@H]\1OC=C(C(C/1=C\C)CC(=O)OC[C@@H]1[C@H]([C@H](O)[C@@H](OC(=O)CC\2C(=CO[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C/2=C/C)C(=O)OC)[C@H](OCCC=2C=CC(O)=CC=2)O1)O)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O MFZDFMOKBMJUGB-CWERYYTKSA-N 0.000 description 1
• HOVAGTYPODGVJG-PZRMXXKTSA-N methyl alpha-D-galactoside Chemical compound CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-PZRMXXKTSA-N 0.000 description 1
• ZBDGHWFPLXXWRD-UHFFFAOYSA-N methyl alpha-L-arabinopyranoside Natural products COC1OCC(O)C(O)C1O ZBDGHWFPLXXWRD-UHFFFAOYSA-N 0.000 description 1
• HOVAGTYPODGVJG-VOQCIKJUSA-N methyl beta-D-galactoside Chemical compound CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-VOQCIKJUSA-N 0.000 description 1
• HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
• WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• WVXIMWMLKSCVTD-UHFFFAOYSA-N mogroside II E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1O WVXIMWMLKSCVTD-UHFFFAOYSA-N 0.000 description 1
• 229930191869 mogroside IV Natural products 0.000 description 1
• OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 1
• WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 1
• TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
• UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
• LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
• BZANQLIRVMZFOS-UHFFFAOYSA-N n-butyl alpha-D-glucopyranoside Natural products CCCCOC1OC(CO)C(O)C(O)C1O BZANQLIRVMZFOS-UHFFFAOYSA-N 0.000 description 1
• DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
• 229940052490 naringin Drugs 0.000 description 1
• 229930019673 naringin Natural products 0.000 description 1
• ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
• ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
• 235000019412 neotame Nutrition 0.000 description 1
• 108010070257 neotame Proteins 0.000 description 1
• HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 229940049964 oleate Drugs 0.000 description 1
• MFZDFMOKBMJUGB-IACYQPSVSA-N oleonuezhenide Natural products COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=CC)[C@@H]1CC(=O)OC[C@H]3O[C@@H](OCCc4ccc(O)cc4)[C@H](OC(=O)C[C@H]5C(=CC)[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)OC=C5C(=O)OC)[C@@H](O)[C@@H]3O MFZDFMOKBMJUGB-IACYQPSVSA-N 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 210000003254 palate Anatomy 0.000 description 1
• ZKSZEJFBGODIJW-UHFFFAOYSA-N passiedulin Natural products OC1C(O)C(O)C(CO)OC1OC(C#N)C1=CC=CC=C1 ZKSZEJFBGODIJW-UHFFFAOYSA-N 0.000 description 1
• LPJAUAFOONIRJB-UHFFFAOYSA-N periandrin II Natural products CC12CCC3(C)CCC(C)(C(O)=O)CC3C1=CCC(C1(CC3)C=O)C2(C)CCC1C(C)(C)C3OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPJAUAFOONIRJB-UHFFFAOYSA-N 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 150000003905 phosphatidylinositols Chemical class 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• HXEACLLIILLPRG-UHFFFAOYSA-N pipecolic acid Chemical compound OC(=O)C1CCCCN1 HXEACLLIILLPRG-UHFFFAOYSA-N 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 150000003085 polypodoside A derivatives Polymers 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• BMXNUTUYWQWEFA-UHFFFAOYSA-N prunasin Natural products OCC1OC(O)C(O)C(O)C1OC(C#N)c2ccccc2 BMXNUTUYWQWEFA-UHFFFAOYSA-N 0.000 description 1
• GWTUHAXUUFROTF-UHFFFAOYSA-N pseudochlorogenic acid Natural products C1C(O)C(O)C(O)CC1(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 GWTUHAXUUFROTF-UHFFFAOYSA-N 0.000 description 1
• 229930185946 pterocaryoside Natural products 0.000 description 1
• MMEPFCTYQGYQJY-UHFFFAOYSA-N pulcherrimine Natural products OC(=O)C(O)CSC1CCNC(C(O)=O)C1 MMEPFCTYQGYQJY-UHFFFAOYSA-N 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• 229960001404 quinidine Drugs 0.000 description 1
• 229960000948 quinine Drugs 0.000 description 1
• 229960000620 ranitidine Drugs 0.000 description 1
• VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
• HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
• 235000019203 rebaudioside A Nutrition 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 1
• BGOFCVIGEYGEOF-UHFFFAOYSA-N salicylaldehyde beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1C=O BGOFCVIGEYGEOF-UHFFFAOYSA-N 0.000 description 1
• ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• WWDDJYHDZQBKBW-UHFFFAOYSA-N scandenoside R7 Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC=C(C)COC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O WWDDJYHDZQBKBW-UHFFFAOYSA-N 0.000 description 1
• 229940096995 sclareolide Drugs 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• XJIPREFALCDWRQ-UHFFFAOYSA-N siamenoside I Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)OC2C(C(O)C(O)C(CO)O2)O)OC1COC1OC(CO)C(O)C(O)C1O XJIPREFALCDWRQ-UHFFFAOYSA-N 0.000 description 1
• PWRIIDWSQYQFQD-UHFFFAOYSA-N sisunine Natural products CC1CCC2(NC1)OC3CC4C5CCC6CC(CCC6(C)C5CCC4(C)C3C2C)OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OC(CO)C(O)C(O)C9OC%10OC(CO)C(O)C(O)C%10O)C8O)C(O)C7O PWRIIDWSQYQFQD-UHFFFAOYSA-N 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• WRZYGPIFICWRCG-OOFFSTKBSA-M sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trih Chemical compound [Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O WRZYGPIFICWRCG-OOFFSTKBSA-M 0.000 description 1
• 210000001584 soft palate Anatomy 0.000 description 1
• 229940031352 solanine Drugs 0.000 description 1
• ZGVSETXHNHBTRK-OTYSSXIJSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-OTYSSXIJSA-N 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000003746 solid phase reaction Methods 0.000 description 1
• 238000010671 solid-state reaction Methods 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 229940001941 soy protein Drugs 0.000 description 1
• 238000003153 stable transfection Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 229930183612 suavioside Natural products 0.000 description 1
• DJGDBVPYRDFFOC-UHFFFAOYSA-N suavioside B Natural products O1C(CO)C(O)C(O)C(O)C1OC(=O)C1(C)CCCC(C2(CC3)O)(C)C1CCC2(C1)CC(=C)C13OC1OC(CO)C(O)C(O)C1O DJGDBVPYRDFFOC-UHFFFAOYSA-N 0.000 description 1
• NGJFUJVMLWRHKV-UHFFFAOYSA-N suavioside C1 Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(COC(=O)C=Cc6ccc(O)cc6)C(O)C(O)C5O)C(=O)OC7OC(CO)C(O)C(O)C7O NGJFUJVMLWRHKV-UHFFFAOYSA-N 0.000 description 1
• RROVYEBHBRTBDC-UHFFFAOYSA-N suavioside D2 Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(O)C5O)C(=O)OC6OC(COC(=O)C=Cc7ccc(O)c(O)c7)C(O)C(O)C6O RROVYEBHBRTBDC-UHFFFAOYSA-N 0.000 description 1
• JRITVVGPSXLNMR-UHFFFAOYSA-N suavioside G Natural products CC1(O)CC2(CCC34)CC1(OC1C(C(O)C(O)C(CO)O1)O)CCC2C3(C)CCCC4(C)C(=O)OC1OC(CO)C(O)C(O)C1O JRITVVGPSXLNMR-UHFFFAOYSA-N 0.000 description 1
• IBXRQQBJPCVMCM-UHFFFAOYSA-N suavioside H Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C=C2C=O)CC12OC1OC(CO)C(O)C(O)C1O IBXRQQBJPCVMCM-UHFFFAOYSA-N 0.000 description 1
• TYIKLWYMBUWTIH-UHFFFAOYSA-N suavioside I Natural products C1C(O)(CO)C(O)(CCC23)CC13CCC1C2(C)CCCC1(C)C(=O)OC1OC(CO)C(O)C(O)C1O TYIKLWYMBUWTIH-UHFFFAOYSA-N 0.000 description 1
• CCUSLDHMJQZSLY-UHFFFAOYSA-N suavioside J Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C=C2CO)CC12OC1OC(CO)C(O)C(O)C1O CCUSLDHMJQZSLY-UHFFFAOYSA-N 0.000 description 1
• LBDVSPIQWSQRLB-UHFFFAOYSA-N sucrononic acid Chemical compound C=1C=C(C#N)C=CC=1\N=C(/NCC(=O)O)NC1CCCCCCCC1 LBDVSPIQWSQRLB-UHFFFAOYSA-N 0.000 description 1
• 229940013883 sucrose octaacetate Drugs 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
• MYMZLBHZVRWYRE-UHFFFAOYSA-N suosan Chemical compound OC(=O)CCNC(=O)NC1=CC=C([N+]([O-])=O)C=C1 MYMZLBHZVRWYRE-UHFFFAOYSA-N 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• VSJGJMKGNMDJCI-QXSNVGMTSA-N sweroside Natural products OC[C@H]1O[C@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O VSJGJMKGNMDJCI-QXSNVGMTSA-N 0.000 description 1
• LILOLDYAQAFVGN-UHFFFAOYSA-N swertiapunimarin Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(C3C(C(OCC3)=O)=CO2)C=C)O1 LILOLDYAQAFVGN-UHFFFAOYSA-N 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 1
• 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• XYNPYHXGMWJBLV-OFMODGJOSA-N tomatidine Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@@H](C)[C@]6(O[C@H]5C4)NC[C@@H](C)CC6)CC3)CC2)CC1 XYNPYHXGMWJBLV-OFMODGJOSA-N 0.000 description 1
• REJLGAUYTKNVJM-SGXCCWNXSA-N tomatine Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@@]1(NC[C@@H](C)CC1)O5)C)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O REJLGAUYTKNVJM-SGXCCWNXSA-N 0.000 description 1
• CWVRJTMFETXNAD-NXLLHMKUSA-N trans-5-O-caffeoyl-D-quinic acid Chemical compound O[C@H]1[C@H](O)C[C@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 238000003151 transfection method Methods 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• RMBMLYUFYBZPCX-XQARLGSBSA-N trifloroside Chemical compound CC(=O)OC[C@H]1O[C@@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(=O)c1cccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1O RMBMLYUFYBZPCX-XQARLGSBSA-N 0.000 description 1
• GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 description 1
• DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 230000009105 vegetative growth Effects 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 239000012130 whole-cell lysate Substances 0.000 description 1
• 239000000811 xylitol Substances 0.000 description 1
• 235000010447 xylitol Nutrition 0.000 description 1
• HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
• 229960002675 xylitol Drugs 0.000 description 1
• 229960000317 yohimbine Drugs 0.000 description 1
• 239000010272 ziziphin Substances 0.000 description 1
• XOFLBQFBSOEHOG-UUOKFMHZSA-N γS-GTP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=S)[C@@H](O)[C@H]1O XOFLBQFBSOEHOG-UUOKFMHZSA-N 0.000 description 1